CWE SAR-1000 Small Animal Ventilator with SAR-COMM software package
12 April, 2018The SAR-1000 Small Animal Ventilator, from CWE, offers a simple and intuitive interface which can be used in conjunction with a variety of different small animals. It delivers respiratory parameters through the use of sensors for airflow and pressure.
ReCell saves skin, reduces treatment costs for burn victims
12 April, 2018AVITA Medical has conducted a pivotal clinical trial demonstrating the effectiveness of its ReCell Autologous Cell Harvesting Device in the treatment of second-degree burns.
Clinical study commences for brain cancer drug
11 April, 2018Kazia Therapeutics' small molecule inhibitor is being developed to treat glioblastoma multiforme — the most common and aggressive form of primary brain cancer.
Phospholipid formulation found to relieve PMS
10 April, 2018A clinical study has indicated the positive effects of Lipogen PMS, a natural phospholipid formulation, in treating and relieving premenstrual syndrome (PMS) symptoms.
Immutep enters clinical trial collaboration, raises $6.85m
21 March, 2018The clinical trial will evaluate the combination of Immutep's lead immunotherapy product candidate with MSD's anti-PD-1 therapy in several different solid tumours.
Skin regeneration trial commences in China
20 March, 2018AVITA Medical has announced the commencement of a clinical trial of its ReCell regenerative medicine technology in the treatment of second-degree burns in China.
Liver inflammation reduced in NASH patients
14 March, 2018Biopharmaceutical company Immuron has announced a new treatment for LPS-related inflammation, based around its development drug IMM-124E.
Biotech spin-off brings together microbes and genomics
13 March, 2018Newly established biotechnology company Microomics has a speciality in metagenomics — the complete genomic analysis of a sample.
Modular hearing aids: functional, rechargeable, beautiful
12 March, 2018A Melbourne researcher has helped design what is claimed to be the world's first modular hearing aid — a breakthrough that took 130 prototypes to get right.
Report questions SA's GM crop ban
09 March, 2018The moratorium on genetically modified crops in South Australia does not deliver price premiums to any farmer in the state, according to market analysis company Mecardo.
Paediatric neuroblastoma could be treated by nanocells
06 March, 2018EnGeneIC's bacterially derived nanocells are enhancing the delivery of chemotherapy to tumours, while limiting toxicity to normal tissues, in aggressive paediatric neuroblastoma.
Trapping the protein servants of drug-resistant bacteria
05 March, 2018Belgian researchers have devised a novel approach to developing antibacterial drugs, in a breakthrough that is set to combat the rise of antibacterial resistance.
US conjunctivitis treatment funded by the MRCF
28 February, 2018Okogen, a developer of ophthalmic anti-infective drugs, has received $13m from the Medical Research Commercialisation Fund to advance its viral conjunctivitis treatment.
'Thought control' enables spinal injury patient to ride a bike
27 February, 2018 by Lauren DavisGold Coast researchers are using a 3D computer-simulated biomechanical model and an electroencephalogram (EEG) to stimulate movement in quadriplegics.
Next-gen antibody shows promise as lung fibrosis treatment
20 February, 2018A locally developed molecule called an 'i-body' serves as a powerful inhibitor of fibroblast migration in human lungs, providing promising evidence for a new treatment of lung fibrosis.
